Scholars Central

Conference abstractPublished 2018

Nanoformulations for dermally application

Authors: Ayse Nur Oktay, Sibel Ilbasmis Tamer, Nevin Celebi

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In pharmacy, most of the attention is focused on improved dermal delivery of poorly soluble drugs. The skin which is the biggest organ in our body has great importance because it provides protection of the organism against environmental factors and organization of body heat and water loss. Thus it forms a suitable region for drug application with its large surface area to obtain local and systemic effects. There are many advantages of dermally application, such as reducing gastrointestinal side effects, providing drug accumulation at the specific region, self-administration of the patient, high patient compliance compared to other drug delivery routes. However, especially stratum corneum layers of skin plays a critical role in limiting the delivery of most drugs, thus the drug permeation through the skin becomes a rate limiting step for absorption. In recent years, several methods have been examined to increase the permeation of drugs into or through the skin. One of the promising approaches is the use of nanoparticulate delivery system such as nanosuspension, solid lipid nanoparticles, nanogels etc. Nanonization of drug particles (100-1000 nm) increase its surface area, dissolution, saturation solubility, permeability and final results is high dermal bioavailability. In our studies, Flurbiprofen (FB) was selected as a model drug which is one of the nonsteroidal anti-inflammatory drugs and it is used to treat gout, arthritis, rheumatoid arthritis and sun burn. But it has low water solubility (BCS Class II). To improve its solubility and thus permeability in or through the skin, FB nanoformulations (nano suspensions and nano gels) were successfully obtained for dermally application. These studies demonstrated that nano formulations are very effective for improving dermal bioavailability of lipophilic drug substances.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in International Journal of Drug Development and Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Drug Development and Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ayse Nur Oktay”
  • BylineArticles whose byline prints “Sibel Ilbasmis Tamer”
  • BylineArticles whose byline prints “Nevin Celebi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels